TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
DXR

Daxor Corporation

Healthcare · Medical Instruments & Supplies

11.30$ -3.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Daxor Corporation (DXR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 46 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DXR
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
37 41 44 36 50 44 42 48 56 60 78 103 77 75 91 86 56 47 46 21 21 19 18 14 17 25 30 35 37 46
1.2 0.4 0.3 0.1 0.1 0.6 0.2 0.1 0.2 59 77 100 74 71 87 82 2.3 0.3 0.3 2.5 2.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 –
0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 2.8 2.0 2.5 0.3 0.1 0.1 – – – 2.5 2.2 1.1 – – 0.6 0.7 – – – –
0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 2.8 2.0 2.5 0.3 0.1 0.1 – – – 2.5 2.2 1.1 – – 0.6 0.7 – – – –
1.1 0.3 0.2 0.0 0.1 0.2 0.2 0.1 0.2 1.2 7.3 10 2.8 17 33 23 2.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 –
– – – – – – – 0.1 0.1 0.2 0.2 0.3 0.4 0.5 0.4 0.3 – – – – – – – – – – – – – –
– – – – 0.3 0.3 0.3 0.3 0.3 0.6 0.8 2.1 2.3 4.2 4.2 4.0 – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – 0.0 – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – 0.0 – – – – – – – – – – – – – –
5.5 8.4 8.8 6.6 11 8.2 8.0 12 16 21 33 48 33 28 44 50 21 21 21 6.5 5.3 5.6 4.6 1.4 0.9 3.8 1.3 0.9 0.8 0.1
0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 21 33 47 33 27 44 49 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.7 0.8 0.1 0.1 0.1 0.1
– – – – – – – – – 0.5 0.4 0.8 2.0 0.4 2.6 0.4 – – 21 3.8 2.8 4.3 4.5 1.3 0.6 0.7 – – – –
0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.5 0.4 0.5 0.6 0.5 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
– – – – – – – – – – – 0.4 0.4 0.3 0.3 0.2 – – 21 3.8 2.8 4.3 4.5 1.3 – – – – – –
32 33 35 29 39 35 34 36 40 39 46 55 43 48 47 36 35 26 25 14 15 14 13 13 16 21 29 34 36 46
19 17 16 16 16 16 16 15 15 14 13 23 32 32 33 25 47 13 11 10 10 8.5 17 17 15 20 25 25 26 35
5.0 5.0 5.0 5.0 4.7 4.7 4.7 4.6 4.6 4.6 4.6 4.6 4.4 4.3 4.2 4.2 4.1 4.1 3.8 3.8 3.8 3.8 3.7 4.2 3.9 4.0 8.6 4.6 4.8 5.0

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?